• Issue

    Catheterization and Cardiovascular Interventions: Volume 98, Issue 7

    i-vii, 1211-1415, E977-E1065
    December 1, 2021
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION – COPYRIGHT

Free Access

Issue Information – Copyright

  • Page: i
  • First Published: 01 December 2021

ISSUE INFORMATION – EDITORIAL BOARD

Free Access

Issue Information – Editorial Board

  • Page: ii
  • First Published: 01 December 2021

ISSUE INFORMATION – TOC

Free Access

Issue Information – TOC

  • Pages: iv-vii
  • First Published: 01 December 2021

CORONARY ARTERY DISEASE

ORIGINAL STUDIES

Mortality in spontaneous coronary artery dissection: A systematic review and meta-analysis

Cobi Adams MD,  Maggie He MD,  Ian Hughes PHD,  Kuljit Singh MBBS, FRACP, PHD, 
  • Pages: 1211-1220
  • First Published: 25 January 2021

EDITORIAL COMMENT

Tobacco and Venus may reduce man to ashes, even when Bacchus is on vacation

Tiziana Claudia Aranzulla MD, MSc,  Giuseppe Musumeci MD, 
  • Pages: 1221-1222
  • First Published: 01 December 2021
Key Points

  • Mortality after spontaneous coronary artery dissection (SCAD) is low, and it is related to baseline cardiovascular risk factors as smoking and sex rather than management strategies.
  • Helping post-SCAD patients to quit smoking and a greater awareness of the possible occurrence of SCAD in men may improve outcomes.
  • Wider studies systematically reporting in-hospital and long-term mortality after SCAD will enhance our knowledge on this heterogeneous clinical entity.

ORIGINAL STUDIES

Characteristics and outcomes of surgically ineligible patients with multivessel disease treated with percutaneous coronary intervention

Mary C. Shields MD,  Michelle Ouellette MD,  Nicholas Kiefer MD,  Luke Kohan MD,  Angela M. Taylor MD,  Gorav Ailawadi MD,  Michael Ragosta MD, 
  • Pages: 1223-1229
  • First Published: 03 February 2021

EDITORIAL COMMENT

Surgical turndowns are not no option patients

George W. Vetrovec MD, 
  • Pages: 1230-1231
  • First Published: December 1, 2021
Key Points

  • Patients with extensive, high-risk coronary artery disease (CAD) deemed surgically ineligible who undergo elective percutaneous coronary intervention (PCI) have better than predicted surgical 30-day outcomes.
  • Risk factors predicting 1-year PCI outcomes include frailty and STS score.
  • Future trials are needed to best assess acceptable risk profiles for PCI in surgical turndowns as well as the impact of procedural characteristics such as completeness of revascularization, hemodynamic support, and image-guided stenting on late outcomes.

ORIGINAL STUDIES

Same day discharge after chronic total occlusion interventions: A single center experience

Michael Koutouzis MD,  Catherine Liontou MD,  Iosif Xenogiannis MD,  Peter Tajti MD,  Ioannis Tsiafoutis MD,  Efstathios Lazaris MD,  Nikolaos Oikonomidis MD,  Eleftherios Kontopodis MD,  Bavana Rangan AD,  Emmanouil Brilakis MD, 
  • Pages: 1232-1239
  • First Published: 13 October 2020

EDITORIAL COMMENT

Everything is outpatient these days: The new economics of sophisticated cardiovascular care

Nachiket J. Patel MD,  Richard R. Heuser MD, 
  • Page: 1240
  • First Published: December 1, 2021
Key Points

  • Same-day discharge (SDD) after percutaneous coronary intervention (PCI) is associated with reduced cost and increased patient satisfaction.
  • This study demonstrates the safety of SDD after uncomplicated chronic total occlusion PCI via the forearm approach.

ORIGINAL STUDIES

Excimer laser coronary atherectomy for uncrossable coronary lesions. A multicenter registry

Soledad Ojeda MD, PhD,  Lorenzo Azzalini MD, PhD, MSc,  Javier Suárez de Lezo MD, PhD,  Gurpreet S. Johal MD,  Rafael González MD,  Nitin Barman MD,  Francisco Hidalgo MD, PhD,  Neus Bellera MD, PhD,  George Dangas MD, PhD,  Alfonso Jurado-Román MD, PhD,  Annapoorna Kini MD,  Miguel Romero MD, PhD,  Raúl Moreno MD, PhD,  Bruno Garcia del Blanco MD, PhD,  Roxana Mehran MD,  Samin K. Sharma MD,  Manuel Pan MD, PhD, 
  • Pages: 1241-1249
  • First Published: 24 November 2020

EDITORIAL COMMENT

Debulking uncrossable lesions with excimer laser: The interplay between device performance and limitations

On Topaz MD, FACP, FSCAI, 
  • Pages: 1250-1251
  • First Published: December 1, 2021
Key Points

  • Excimer laser successfully debulks atherosclerotic plaques, noteworthy lesions that fail to yield (uncrossable) to standard tools.
  • Severe calcifications serve as an independent predictor of laser failure to recanalize uncrossable lesions, whereby other debulking technologies may better succeed.
  • Q-T prolongation during lasing represents dynamic ischemia caused either by impaired flow or distal spasm, leading to development of severe arrhythmias, thus, proper lasing techniques remain essential.

ORIGINAL STUDIES

Revascularisation strategies in patients with significant left main coronary disease during the COVID-19 pandemic

Mohamed O. Mohamed MRCP,  Nick Curzen PhD FRCP,  Mark de Belder MD FRCP,  Andrew T. Goodwin PhD FRCS(CTh),  James C Spratt MD,  Lognathen Balacumaraswami MD,  John Deanfield FRCP,  Glen P. Martin PhD,  Muhammad Rashid PhD,  Ahmad Shoaib MD,  Chris P Gale PhD FRCP,  Tim Kinnaird MD,  Mamas A. Mamas DPhil, 
  • Pages: 1252-1261
  • First Published: 25 March 2021

EDITORIAL COMMENT

Left main coronary revascularization strategies in the COVID-19 era

Ran Kornowski MD, FESC, FACC, 
  • Pages: 1262-1263
  • First Published: 01 December 2021
Key Points

  • In a UK national analysis of a contemporary procedural cohort, the authors demonstrated that left main (LM) revascularization has significantly declined during the initial wave period of COVID-19, with a clear shift towards PCI as the preferred revascularization strategy.
  • Adjusted in-hospital and 30-day mortality within each revascularization group was similar in the pre-COVID and COVID periods, reflecting a maintenance in quality of short-term outcomes following LM revascularization.
  • More data are required to explain this phenomenon and to explore the long-term outcomes and temporal trands data.

ORIGINAL STUDIES

Mechanical circulatory support in acute myocardial infarction and cardiogenic shock: Challenges and importance of randomized control trials

Mir B. Basir DO,  Duane S. Pinto MD,  Boback Ziaeian MD, PhD,  Akshay Khandelwal MD,  Jennifer Cowger MD,  William Suh MD,  Andrew Althouse PhD, 
  • Pages: 1264-1274
  • First Published: 07 March 2021

Predicting mortality in cardiogenic shock secondary to ACS requiring short-term mechanical circulatory support: The ACS-MCS score

Qussay Marashly MD,  Iosif Taleb MD,  Christos P. Kyriakopoulos MD,  Elizabeth Dranow PhD,  Tara L. Jones MD, PharmD,  Anwar Tandar MD,  Sean D. Overton MD,  Joseph E. Tonna MD, MS,  Kathleen Stoddard RN,  Omar Wever-Pinzon MD,  Line Kemeyou MD,  Antigone G. Koliopoulou MD,  Kevin S. Shah MD,  Kimiya Nourian BS, MS,  Tyler J. Richins BS,  Tyson S. Burnham BS,  Frederick G. Welt MD,  Stephen H. McKellar MD, MSc,  Jose Nativi-Nicolau MD,  Stavros G. Drakos MD, PhD, 
  • Pages: 1275-1284
  • First Published: 07 March 2021

EDITORIAL COMMENT

Risk prediction in cardiogenic shock

Matthew I. Tomey MD,  George D. Dangas MD, PhD, 
  • Pages: 1285-1286
  • First Published: 01 December 2021
Key Points

  • A new ACS-MCS risk score incorporating age, lactate, acute kidney injury, and SCAI Shock class predicts 30-day mortality in patients receiving short-term mechanical circulatory support for cardiogenic shock complicating acute coronary syndromes.
  • This study illustrates that shock severity, as defined by SCAI Shock class, is one of multiple key factors influencing mortality in cardiogenic shock.
  • Age and end-organ injury are important mediators of cardiogenic shock outcomes.

ORIGINAL STUDIES

Predicting 2-year all-cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX score

Ply Chichareon MD,  David van Klaveren PhD,  Rodrigo Modolo MD,  Norihiro Kogame MD,  Kuniaki Takahashi MD,  Chun-Chin Chang MD,  Mariusz Tomaniak MD,  Jinqing Yuan MD,  Lihua Xie MSc,  Ying Song MD,  Shubin Qiao MD,  Yuejin Yang MD,  Changdong Guan MSc,  Aleksander Zurakowski MD, PhD,  Robert-Jan van Geuns MD, PhD,  Manel Sabate MD,  Paul J. Ong MD,  Joanna J. Wykrzykowska MD, PhD,  Jan J. Piek MD, PhD,  Scot Garg MBChB, PhD,  Christian Hamm MD,  Gabriel Steg MD,  Pascal Vranckx MD, PhD,  Marco Valgimigli MD, PhD,  Stephan Windecker MD,  Peter Juni MD,  Yoshinobu Onuma MD, PhD,  Ewout Steyerberg PhD,  Bo Xu MBBS,  Patrick W. Serruys MD, PhD, 
  • Pages: 1287-1297
  • First Published: 04 February 2021

EDITORIAL COMMENT

Predicting mortality after percutaneous coronary intervention: The need for improved risk models

Anirudh Kumar MD MSc,  Hani Jneid MD, 
  • Pages: 1298-1299
  • First Published: December 1, 2021
Key Points

  • In the contemporary era of personalized medicine, accurate risk assessment following percutaneous coronary intervention (PCI) is important for patient selection and to guide the shared decision-making process by patients and interventional cardiologists.
  • The updated clinical logistic SYNTAX score incorporates the following five additional independent predictors into the risk model: history of lung disease, prior stroke, current smoking, hemoglobin level, and white blood cell count.
  • Compared with the old model, the updated clinical logistic SYNTAX score has improved discriminative ability for predicting 2-year mortality after PCI.

ORIGINAL STUDIES

Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30-day outcomes in the elderly

James Cockburn MD,  Tiffany Kemp MBBS,  Peter Ludman MD,  Tim Kinnaird MD,  Tom Johnson MD,  Nick Curzen PhD,  Derek Robinson BSc,  Mamas Mamas PhD,  Adam de Belder MD,  David Hildick-Smith MD,  The British Cardiovascular Intervention Society (BCIS) , 
  • Pages: 1300-1307
  • First Published: 06 December 2020

EDITORIAL COMMENT

You are only as old as you feel? It may depend on your score

Samuel M. Butman MD, FSCAI, 
  • Page: 1308
  • First Published: December 1, 2021
Key Points

  • Getting old makes you think more.
  • Hopefully those caring for you when you are old, will think more, too.
  • The preceding report gives a background for what parameters should be weighed prior to possible intervention in an elderly patient.

ORIGINAL STUDIES

Low hemoglobin predicts high-platelet reactivity and major cardiovascular ischemic events at long-term follow-up among ACS patients receiving dual antiplatelet therapy with ticagrelor

Monica Verdoia MD,  Roberta Rolla MD,  Patrizia Pergolini MD,  Rocco Gioscia MD,  Matteo Nardin MD,  Federica Negro MD,  Filippo Viglione MD,  Harry Suryapranata MD, PhD,  Elvin Kedhi MD,  Giuseppe De Luca MD, PhD,  Novara Atherosclerosis Study Group (NAS) , 
  • Pages: 1309-1316
  • First Published: 01 February 2021

Utilization and outcomes of transcatheter coil embolization for various coronary artery lesions: Single-center 12-year experience

Omar M. Abdelfattah MD,  Anas M. Saad MD,  Nicholas Kassis MD,  Shashank Shekhar MD,  Toshiaki Isogai MD, MPH,  Mohamed M. Gad MD,  Keerat R. Ahuja MD,  Essa Hariri MD,  Manpreet Kaur MD,  Medhat Farwati MD,  Jaikirshan Khatri MD,  Amar Krishnaswamy MD,  Samir R. Kapadia MD, 
  • Pages: 1317-1331
  • First Published: 18 November 2020

EDITORIAL COMMENT

When and how to close vessels in the cardiac catheterization laboratory

Spyridon Kostantinis MD,  Emmanouil S. Brilakis MD, PhD, 
  • Pages: 1332-1334
  • First Published: December 1, 2021
Key Points

  • Coil embolization can be used to occlude various vessels and structures in the cardiac catheterization laboratory, such as coronary artery fistulas, left internal mammary artery side branches, coronary artery perforations, and coronary artery aneurysms and pseudoaneurysms.
  • Coiling can be achieved with high success and low complication rates.
  • Since coiling is performed infrequently in the cardiac catheterization laboratory, stocking an appropriate, limited selection of 0.014 inch detachable coils and learning how to deliver and deploy them can literally be a “life saver”!

ORIGINAL STUDIES

Healing and early stent coverage after ultrathin strut biodegradable polymer-coated sirolimus-eluting stent implantation: SiBi optical coherence tomography study

Atul Abhyankar MD, DM,  Alexandre Abizaid MD, PhD,  Daniel Chamié MD, PhD,  Gaurang Patel MD, 
  • Pages: 1335-1342
  • First Published: 28 November 2020

CASE REPORT

Revascularization by percutaneous coronary intervention in a case of left main coronary artery atresia

Tao Yin MD,  Xin Zhong MD,  Ling Tao MD,  Tao Hu MD, 
  • Pages: 1343-1348
  • First Published: 19 August 2021

INTERVENTIONAL ROUNDS

The appropriate use criteria: Improvements for its integration into real world clinical practice

Lloyd W Klein MD,  Jacqueline Tamis-Holland MD,  Ajay J Kirtane MD, SM,  H Vernon Anderson MD,  Joaquin Cigarroa MD,  Peter L Duffy MD,  James Blankenship MD, MACC,  C. Michael Valentine MD, MACC,  Frederick GP Welt MD,  For The AUC Workgroup of the ISLC Endorsed by the Interventional Section Leadership Council, American College of Cardiology , 
  • Pages: 1349-1357
  • First Published: 03 June 2021

PEDIATRIC AND CONGENITAL HEART DISEASE

CASE REPORT

Restriction of congenital portosystemic shunt using the modified microvascular plug

Sruti Rao MD,  Karunakaravel Karuppasamy MD,  Kadakkal Radhakrishnan MD,  Thomas E. Fagan MD, 
  • Pages: 1358-1362
  • First Published: 06 September 2021

PERIPHERAL VASCULAR DISEASE

ORIGINAL STUDIES

Development and validation of a predictive model for bleeding after peripheral vascular intervention: A report from the National Cardiovascular Data Registry Peripheral Vascular Interventions Registry

Adam C. Salisbury MD, MSc,  David M. Safley MD,  Kevin F. Kennedy MS,  Bhaskar Bhardwaj MD,  Herbert D. Aronow MD, MPH,  William Schuyler Jones MD,  Dmitriy N. Feldman MD,  Eric Secemsky MD, MSc,  Thomas T. Tsai MD, Msc,  Robert R. Attaran MBBS,  John A. Spertus MD, MPH, 
  • Pages: 1363-1372
  • First Published: 27 September 2021

EDITORIAL COMMENT

Do we have an ideal bleeding prediction scoring system yet?

Mehmet Cilingiroglu MD,  Ismail Dogu Kilic MD, 
  • Pages: 1373-1374
  • First Published: 01 December 2021
Key Points

  • Major bleeding is a frequent periprocedural complication of peripheral vascular interventions.
  • An integer scoring system can be used to stratify patients according to their bleeding risk.
  • Use of risk prediction scores may improve outcomes in PVI procedures; however, further studies are needed.

ORIGINAL STUDIES

Open Access

Finding the optimal access for proximal upper limb artery (PULA) interventions: Lessons learned from the PULA multicenter registry

Sándor Nardai MD, PhD,  Biljana Zafirovska MD,  Ákos Pataki MD,  Balázs Nemes MD, PhD,  Júlia Tóth MD,  Mónika Deák MD,  Sasko Kedev MD, PhD,  Olivier Francois Bertrand MD, PHD,  Charles Pirlet MD,  Béla Merkely MD, PhD,  Zoltán Ruzsa MD, PhD, 
  • Pages: 1375-1382
  • First Published: 29 September 2021

VALVULAR AND STRUCTURAL HEART DISEASES

ORIGINAL STUDIES

Outflow graft obstruction in patients with the HM 3 LVAD: A percutaneous approach

Assi Milwidsky MD,  Miguel Alvarez Villela MD,  Jose Wiley MD MPH,  Cristina Sanina MD,  Snehal R. Patel MD,  Nicole Sutton MD,  Azeem Latib MD,  Daniel B. Sims MD,  Stephen J. Forest MD,  Julia J. Shin MD,  Muhammad U. Farooq MD,  Daniel J. Goldstein MD,  Ulrich P Jorde MD, 
  • Pages: 1383-1390
  • First Published: 28 May 2021

CORONARY ARTERY DISEASE

EDITORIAL COMMENT

Outflow graft obstruction in patients with left ventricular assist devices: Stenting the kink

Alexander Postalian MD,  Zvonimir Krajcer MD, 
  • Pages: 1391-1392
  • First Published: 01 December 2021
Key Points

  • Outflow graft obstruction (OGO) is a feared complication in patients with left ventricular assist devices.
  • It can be caused by graft kinking or twisting, external compression, or internal material deposition.
  • The best endovascular approach for treating this complication is not well established.
  • The authors report their institutional experience treating OGO in patients with HeartMate 3 devices, describing a straightforward approach that appears safe and feasible for a large proportion of patients.

VALVULAR AND STRUCTURAL HEART DISEASES

ORIGINAL STUDIES

Procedural planning of CS-based indirect mitral annuloplasty using CT-angiography

Dennis Rottländer MD,  Miriel Gödde MD,  Hubertus Degen MD,  Alev Ögütcü MD,  Martin Saal MD,  Michael Haude MD, 
  • Pages: 1393-1401
  • First Published: 25 June 2021

EDITORIAL COMMENT

Prediction of left circumflex artery impingement after indirect mitral annuloplasty with the carillon device: “There is more to this than meets the eye!”

Issam D. Moussa MD, MBA, 
  • Pages: 1402-1403
  • First Published: 01 December 2021
Key Points

  • CT angiography prior to indirect mitral annuloplasty with the Carillon device may provide useful information for prediction of left circumflex artery (LCX) impingement.
  • Application of coronary sinus to LCX distance, as a predictor of LCX impingement, needs further validation.
  • Future studies should examine anatomic predictors of LCX impingement within well-defined pathophysiological subsets of patients with functional mitral regurgitation.

ORIGINAL STUDIES

Integrative echocardiographic assessment of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair

Nicolas Brugger MD,  Mohammad Kassar MD,  George C. M. Siontis MD,  Sonja Widmer MD,  Taishi Okuno MD,  Mirjam G. Winkel MD,  Noé Corpataux MD,  Christoph Gräni MD,  Lutz Büllesfeld MD,  Lukas Hunziker MD,  Thomas Pilgrim MD,  Stephan Windecker MD,  Fabien Praz MD, 
  • Pages: 1404-1412
  • First Published: 18 August 2021

EDITORIAL COMMENT

Transcatheter edge-to-edge mitral valve repair: Should we stay tied to COAPT tiers?

Francesco Saia MD, PhD, 
  • Pages: 1413-1414
  • First Published: 01 December 2021
Key Points

  • What the article teaches. Patients with secondary mitral regurgitation (SMR) undergoing transcatheter edge-to-edge mitral valve repair (TEER) have different prognosis based on eligibility criteria in the COAPT trial and on different echocardiographic tiers for enrollment in the same trial.
  • How it will impact practice. Patient selection for TEER should be based on an integrative approach rather than on a single parameter, and largely guided by the COAPT trial enrollment criteria.
  • What new research/study would help answer the question posed. Further studies are needed to clearly identify patients subgroups that could benefit from TEER and, within them, to identify parameters that may help stratifying patients with different outcomes.

CORONARY ARTERY DISEASE

LETTER TO THE EDITOR

The CathPCI Registry (still) welcomes ambulatory surgical center participation

Kendrick A. Shunk MD, PhD, FSCAI, 
  • Page: 1415
  • First Published: 16 September 2021

INTERVENTIONAL ROUNDS

Coronary stent positioning under live IVUS guidance in low contrast percutaneous coronary interventions: The live IVUS stenting technique

Hady Lichaa MD, FSCAI, FSVM, RPVI, 
  • Pages: E977-E984
  • First Published: 31 August 2021

PERIPHERAL VASCULAR DISEASE

CASE REPORT

Percutaneous closure of a post-surgical ascending aortic pseudoaneurysm with an amplatzer septal occluder device and steerable guiding sheath

Graham R. McClure MD, MSc,  Geemitha Ratnayake BSc,  Albert Chan MD, MSc,  Joel Gagnon MD, 
  • Pages: E985-E989
  • First Published: 29 September 2021

VALVULAR AND STRUCTURAL HEART DISEASES

ORIGINAL STUDIES

Comparison of permanent pacemaker implantation rate after first and second generation of transcatheter aortic valve implantation–A retrospective cohort study

Sa'ar Minha MD,  Yuval Yarkoni BMSc,  Amit Segev MD,  Ariel Finkelstein MD,  Haim Danenberg MD,  Paul Fefer MD,  Katia Orvin MD,  Arie Steinvil MD,  Elad Maor MD, PHD,  Roy Beinart MD,  Raphael Rosso MD,  Gregory Golovchiner MD,  Ran Kornowski MD,  Victor Guetta MD,  Israel M. Barbash MD, 
  • Pages: E990-E999
  • First Published: 04 August 2021
Open Access

Implications of concomitant obstructive or restrictive pulmonary diseases on functional and clinical results after MitraClip

Leonhard Moritz Schneider MD,  Nita Nicoleta MD,  Niklas Schepperle MD,  Michael Paukovitsch MD,  Uli Haide MD,  Sieglinde Feuerabendt MD,  Mirjam Keßler MD,  Wolfgang Rottbauer MD,  Sinisa Markovic MD, 
  • Pages: E1000-E1006
  • First Published: 06 August 2021

Direct oral anticoagulants in patients with atrial fibrillation and bioprosthetic valve replacement: A meta-analysis

Spencer C. Lacy MD, MPH,  Garly R. Saint Croix MD,  Kadijah Porter MD,  Azeem Latib MD,  Nirat Beohar MD, 
  • Pages: E1007-E1016
  • First Published: 12 August 2021

Prophylactic permanent pacemaker strategy in patients with right bundle branch block undergoing transcatheter aortic valve replacement

Motoki Fukutomi MD,  Thijmen Hokken MD,  Ivan Wong MD,  Gintautas Bieliauskas MD,  Joost Daemen MD, PhD,  Peter de Jaegere MD, PhD,  Nicolas Van Mieghem MD, PhD,  Lars Søndergaard MD, DMSc,  Ole De Backer MD, PhD, 
  • Pages: E1017-E1025
  • First Published: 14 August 2021

30-day readmission following urgent and elective transcatheter aortic valve replacement: A Nationwide Readmission Database analysis

Birendra Amgai MBBS,  Neelkumar Patel MD,  Sandipan Chakraborty MD, MBBS,  Dhrubajyoti Bandyopadhyay MBBS, MD,  Adrija Hajra MBBS, MD, MRCP (UK),  Soniya Koirala MD,  Raktim K. Ghosh MBBS, MD, FACP,  Wilbert S. Aronow MD,  Carl J. Lavie MD,  Gregg C. Fonarow MD,  J. Dawn Abbott MD,  Samir Kapadia MD, 
  • Pages: E1026-E1032
  • First Published: 19 August 2021

Surgical versus transcatheter aortic valve replacement in low-risk patients: A long-term propensity score-matched analysis

Catarina Brízido MD,  Márcio Madeira MD,  João Brito MD,  Sérgio Madeira MD,  Rui Campante Teles MD,  Luís Raposo MD,  Henrique Mesquita Gabriel MD,  Tiago Nolasco MD,  Pedro de Araújo Gonçalves MD, PhD,  Miguel Sousa-Uva MD, PhD,  Miguel Abecasis MD,  Manuel de Sousa Almeida MD, PhD,  José Pedro Neves MD,  Miguel Mendes MD, 
  • Pages: E1033-E1043
  • First Published: 10 September 2021

The clinical impact of chronic liver disease in patients undergoing transcatheter and surgical aortic valve replacement: Systematic analysis of the 2011–2017 US hospital database

David Uihwan Lee MD,  John Han MS,  Gregory Hongyuan Fan BA,  David Jeffrey Hastie BA,  Jean Kwon BS,  Ki Jung Lee BS,  Elyse Ann Addonizio BA,  Raffi Karagozian MD, 
  • Pages: E1044-E1057
  • First Published: 25 September 2021

Impact of diabetes mellitus on outcome after transcatheter aortic valve replacement: Identifying high-risk diabetic population from the OCEAN-TAVI registry

Shingo Matsumoto MD,  Yohei Ohno MD,  Junichi Miyamoto MD,  Yuji Ikari MD,  Norio Tada MD,  Toru Naganuma MD,  Masahiro Yamawaki MD,  Futoshi Yamanaka MD,  Shinichi Shirai MD,  Kazuki Mizutani MD,  Minoru Tabata MD,  Hiroshi Ueno MD,  Kensuke Takagi MD,  Yusuke Watanabe MD,  Masanori Yamamoto MD,  Kentaro Hayashida MD,  The OCEAN-TAVI Investigators , 
  • Pages: E1058-E1065
  • First Published: 06 October 2021